Published :
Tables : 43
Figures : 41
Category : Healthcare
No. of Pages : 210
Report Code : HC-U3239
Defibrillators Market is poised to value over CAGR of over 3.1% during the forecast period 2022 to 2028. The primary factors driving the growth of the market are the increased occurance of target diseases, rising emphasis on providing public access defibrillators and creation of awareness pertaining to the usage of defibrillators. FutureWise Market Research has instantiated a report that provides an intricate analysis of Defibrillators Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Defibrillators Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Defibrillators Market: • Medtronic • St. Jude Medical LLC • Boston Scientific Corporation • Physio-Control Inc. • LivaNova • MS Westfalia GmbH • Koninklijke Philips N.V. • Schiller AG • ZOLL Medical Corporation • Cardiac Science • Nihon Kohden Corporation • Defibtech LLC • Progetti Srl • AMI Italia, Ltd. • Biotronik • CU Medical Systems • Mediana • Metsis Medikal • Microport • Mindray Medical (Note: The list of the major players will be updated with the latest market scenario and trends) Defibrillators Market Segmentation: By Type • Implantable Cardioverter Defibrillators (ICDs) o Transvenous Implantable Cardioverter Defibrillators o Subcutaneous Implantable Cardioverter Defibrillators • External Defibrillators o Manual & Semi-Automated External Defibrillators o Fully Automated External Defibrillators o Wearable Cardioverter Defibrillators By End User • Hospitals, Clinics, and Cardiac Centers • Prehospital Care Settings • Public Access Markets • Home Care Settings • Alternate Care Facilities By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the Defibrillators Market By Type, By End User and By Region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The primary factors driving the growth of the market are the increased occurance of target diseases, rising emphasis on providing public access defibrillators and creation of awareness pertaining to the usage of defibrillators.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Defibrillators Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Defibrillators Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Defibrillators Market: • Medtronic • St. Jude Medical LLC • Boston Scientific Corporation • Physio-Control Inc. • LivaNova • MS Westfalia GmbH • Koninklijke Philips N.V. • Schiller AG • ZOLL Medical Corporation • Cardiac Science • Nihon Kohden Corporation • Defibtech LLC • Progetti Srl • AMI Italia, Ltd. • Biotronik • CU Medical Systems • Mediana • Metsis Medikal • Microport • Mindray Medical
(Note: The list of the major players will be updated with the latest market scenario and trends)
Defibrillators Market Segmentation:
By Type
• Implantable Cardioverter Defibrillators (ICDs) o Transvenous Implantable Cardioverter Defibrillators o Subcutaneous Implantable Cardioverter Defibrillators • External Defibrillators o Manual & Semi-Automated External Defibrillators o Fully Automated External Defibrillators o Wearable Cardioverter Defibrillators
By End User
• Hospitals, Clinics, and Cardiac Centers • Prehospital Care Settings • Public Access Markets • Home Care Settings • Alternate Care Facilities
By Region
• North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Defibrillators Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Defibrillators Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Defibrillators Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Defibrillators Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Implantable Cardioverter Defibrillators (ICDs) 7.1.1. Transvenous Implantable Cardioverter Defibrillators 7.1.2. Subcutaneous Implantable Cardioverter Defibrillators 7.2. External Defibrillators 7.2.1. Manual & Semi-Automated External Defibrillators 7.2.2. Fully Automated External Defibrillators 7.2.3. Wearable Cardioverter Defibrillators 8. Global Defibrillators Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Hospitals, Clinics, and Cardiac Centers 8.2. Prehospital Care Settings 8.3. Public Access Markets 8.4. Home Care Settings 8.5. Alternate Care Facilities 9. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028 10. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Regional Market Trends 10.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.3.1. Brazil 10.3.2. Venezuela 10.3.3. Argentina 10.3.4. Rest of Latin America 10.4. Market Size (USD Million) Forecast for Latin America 2022-2028 11. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Switzerland 11.2.9. Rest of Western Europe 12. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. Singapore 12.2.4. India 12.2.5. Australia and New Zealand 12.2.6. ASEAN 12.2.7. South Korea 12.2.8. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 13. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts) 14.1. Medtronic 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. St. Jude Medical LLC 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Boston Scientific Corporation 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Physio-Control Inc. 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. LivaNova 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. MS Westfalia GmbH 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Koninklijke Philips N.V 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. Schiller AG 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. ZOLL Medical Corporation 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10. Cardiac Science 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11. Nihon Kohden Corporation 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 14.12. Defibtech LLC 14.12.1. Company Overview 14.12.2. Product Portfolio 14.12.3. SWOT Analysis 14.12.4. Financial Overview 14.12.5. Strategic Overview 14.13. Progetti Srl 14.13.1. Company Overview 14.13.2. Product Portfolio 14.13.3. SWOT Analysis 14.13.4. Financial Overview 14.13.5. Strategic Overview 14.14. AMI Italia, Ltd. 14.14.1. Company Overview 14.14.2. Product Portfolio 14.14.3. SWOT Analysis 14.14.4. Financial Overview 14.14.5. Strategic Overview 14.15. Biotronik 14.15.1. Company Overview 14.15.2. Product Portfolio 14.15.3. SWOT Analysis 14.15.4. Financial Overview 14.15.5. Strategic Overview 14.16. CU Medical Systems 14.16.1. Company Overview 14.16.2. Product Portfolio 14.16.3. SWOT Analysis 14.16.4. Financial Overview 14.16.5. Strategic Overview 14.17. Mediana 14.17.1. Company Overview 14.17.2. Product Portfolio 14.17.3. SWOT Analysis 14.17.4. Financial Overview 14.17.5. Strategic Overview 14.18. Metsis Medikal 14.18.1. Company Overview 14.18.2. Product Portfolio 14.18.3. SWOT Analysis 14.18.4. Financial Overview 14.18.5. Strategic Overview 14.19. Microport 14.19.1. Company Overview 14.19.2. Product Portfolio 14.19.3. SWOT Analysis 14.19.4. Financial Overview 14.19.5. Strategic Overview 14.20. Mindray Medical 14.20.1. Company Overview 14.20.2. Product Portfolio 14.20.3. SWOT Analysis 14.20.4. Financial Overview 14.20.5. Strategic Overview 15. Pre and Post COVID-19 Impact 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16. FutureWise SME key takeaway points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global Defibrillators Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Defibrillators Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Defibrillators Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Defibrillators Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Implantable Cardioverter Defibrillators (ICDs) 7.1.1. Transvenous Implantable Cardioverter Defibrillators 7.1.2. Subcutaneous Implantable Cardioverter Defibrillators 7.2. External Defibrillators 7.2.1. Manual & Semi-Automated External Defibrillators 7.2.2. Fully Automated External Defibrillators 7.2.3. Wearable Cardioverter Defibrillators
8. Global Defibrillators Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Hospitals, Clinics, and Cardiac Centers 8.2. Prehospital Care Settings 8.3. Public Access Markets 8.4. Home Care Settings 8.5. Alternate Care Facilities
9. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028
10. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Regional Market Trends 10.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.3.1. Brazil 10.3.2. Venezuela 10.3.3. Argentina 10.3.4. Rest of Latin America 10.4. Market Size (USD Million) Forecast for Latin America 2022-2028
11. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Switzerland 11.2.9. Rest of Western Europe
12. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. Singapore 12.2.4. India 12.2.5. Australia and New Zealand 12.2.6. ASEAN 12.2.7. South Korea 12.2.8. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
13. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts) 14.1. Medtronic 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. St. Jude Medical LLC 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Boston Scientific Corporation 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Physio-Control Inc. 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. LivaNova 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. MS Westfalia GmbH 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Koninklijke Philips N.V 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. Schiller AG 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. ZOLL Medical Corporation 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10. Cardiac Science 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11. Nihon Kohden Corporation 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 14.12. Defibtech LLC 14.12.1. Company Overview 14.12.2. Product Portfolio 14.12.3. SWOT Analysis 14.12.4. Financial Overview 14.12.5. Strategic Overview 14.13. Progetti Srl 14.13.1. Company Overview 14.13.2. Product Portfolio 14.13.3. SWOT Analysis 14.13.4. Financial Overview 14.13.5. Strategic Overview 14.14. AMI Italia, Ltd. 14.14.1. Company Overview 14.14.2. Product Portfolio 14.14.3. SWOT Analysis 14.14.4. Financial Overview 14.14.5. Strategic Overview 14.15. Biotronik 14.15.1. Company Overview 14.15.2. Product Portfolio 14.15.3. SWOT Analysis 14.15.4. Financial Overview 14.15.5. Strategic Overview 14.16. CU Medical Systems 14.16.1. Company Overview 14.16.2. Product Portfolio 14.16.3. SWOT Analysis 14.16.4. Financial Overview 14.16.5. Strategic Overview 14.17. Mediana 14.17.1. Company Overview 14.17.2. Product Portfolio 14.17.3. SWOT Analysis 14.17.4. Financial Overview 14.17.5. Strategic Overview 14.18. Metsis Medikal 14.18.1. Company Overview 14.18.2. Product Portfolio 14.18.3. SWOT Analysis 14.18.4. Financial Overview 14.18.5. Strategic Overview 14.19. Microport 14.19.1. Company Overview 14.19.2. Product Portfolio 14.19.3. SWOT Analysis 14.19.4. Financial Overview 14.19.5. Strategic Overview 14.20. Mindray Medical 14.20.1. Company Overview 14.20.2. Product Portfolio 14.20.3. SWOT Analysis 14.20.4. Financial Overview 14.20.5. Strategic Overview 15. Pre and Post COVID-19 Impact 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics